Clinical Trials

Breast Neoplasms

NCT03971409 2026-04-17

InCITe

145 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05081492 2026-04-17

CF33-hNIS-antiPDL1 for the Treatment of Metastatic Triple Negative Breast Cancer

9 enrolled

Phase EARLY_PHASE1 Active not recruiting

Triple Negative Breast Neoplasms

NCT02744053 2026-04-16

DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer

96 enrolled

Phase 1/2 Active not recruiting

Triple Negative Breast Neoplasms

NCT03377387 2026-04-16

Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer

34 enrolled

Breast Neoplasms

NCT03435952 2026-04-16

Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT

18 enrolled

BreastGenitourinary

Breast Neoplasms, Urologic Neoplasms

NCT04125914 2026-04-16

Weight Management and Health Behavior Intervention in Lowering Cancer Risk for BRCA Positive and Lynch Syndrome Families

384 enrolled

BreastGastrointestinal

Breast Cancer, Familial, Colorectal Neoplasms, Hereditary Nonpolyposis

NCT04267796 2026-04-16

Lifestyle Intervention for the Reduction of Breast Cancer Risk in Normal Weight Women

40 enrolled 9 charts

Breast Neoplasms

NCT02754752 2026-04-15

Electroacupuncture Therapy in Reducing Chronic Pain in Patients After Breast Cancer Treatment

111 enrolled

Breast Neoplasms

NCT02876107 2026-04-15

Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer

42 enrolled

Breast Neoplasms, Edema, Erythema, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03162627 2026-04-15

Selumetinib and Olaparib in Solid Tumors

90 enrolled

Breast Neoplasms

NCT03168737 2026-04-15

18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in Patients

25 enrolled

BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Pancreatic Neoplasms

NCT03546972 2026-04-15

Diabetes Prevention Program With or Without Hunger Training in Helping to Lower Breast Cancer Risk in Obese Participants

51 enrolled

BreastOther

Carcinoma, Intraductal, Noninfiltrating, Obesity, Overweight

NCT04920708 2026-04-14

FAIM

57 enrolled

Breast Neoplasms

NCT03503799 2026-04-13

RESCUE

1,191 enrolled

Breast Neoplasms

NCT03650894 2026-04-13

Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients

30 enrolled

Breast Neoplasms

NCT04248257 2026-04-13

Peer Support For Young Adult Women With High Breast Cancer Risk

560 enrolled

Breast Cancer Risk

NCT04522648 2026-04-13

PROTECT

250 enrolled

Breast Neoplasms, Lymphedema

NCT04895761 2026-04-13

Neoadjuvant DPX-Survivac Aromatase Inhibition, Radiotherapy or Cyclophosphamide in HR+HER2- Breast Cancer

6 enrolled

Breast Neoplasms

NCT05215769 2026-04-13

A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients With Metastatic Cancer

243 enrolled 11 charts

BreastThoracic

Breast Neoplasms, Lung Neoplasms, Neoplasm Metastasis

NCT06663787 2026-04-13

HER2 CR

50 enrolled

Phase 1/2 Active not recruiting

Breast Neoplasms, Neoplasm Metastasis, Neoplasm, Residual

NCT03964532 2026-04-09

TALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer

24 enrolled

Breast Neoplasms

NCT06995703 2026-04-09

I-SCREEN Rep

8,490 enrolled

Breast Neoplasms

NCT00579514 2026-04-07

Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients

BreastGastrointestinalGenitourinaryGynecologicThoracic

21,081 enrolled

Urinary Bladder Neoplasms, Breast Neoplasms, Colonic Neoplasms, Kidney Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms

NCT01450020 2026-04-07

Peer Navigator Education in Improving Survivorship Care in African American Breast Cancer Survivors

145 enrolled

Phase 4 Active not recruiting

Breast Neoplasms

NCT04549207 2026-04-07

Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer

240 enrolled

Breast Neoplasms

NCT06604858 2026-04-07

TELESCOPE

31 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07515300 2026-04-07

ARM-LIFE

Breast Neoplasms

NCT03822312 2026-04-06

A Pilot Study of Tomographic Optical Breast Imaging (DBT-TOBI) to Monitor Response to Neoadjuvant Therapy

30 enrolled

Breast Neoplasms

NCT05703269 2026-04-06

HYPOGRYPHE

BreastCNSDermatologicGenitourinaryThoracic

58 enrolled

Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Small Cell Lung Carcinoma

NCT02295059 2026-04-03

Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention

80 enrolled

Breast Neoplasms

NCT03428802 2026-04-03

Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability

21 enrolled 9 charts

BreastGynecologic

Breast Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms

NCT06874985 2026-04-03

Effectiveness and Impact of the Lived Experience Cancer Awareness Campaign on Screening Participation

BreastGynecologicHead & Neck

1,120 enrolled

Breast Neoplasms, Uterine Cervical Neoplasms, Mouth Neoplasms

NCT06878248 2026-04-03

A Study to Assess CLBR001+ABBV-461 in Subjects With Locally Advanced or Metastatic Breast Cancer

20 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04569747 2026-04-02

ADEPT

393 enrolled

Phase 4 Active not recruiting

Breast Neoplasms

NCT05754528 2026-04-02

REaCT-TEMPO

240 enrolled

Breast Neoplasms

NCT04993313 2026-04-01

Standard Verbal Counseling With or Without a Pictorial Educational Tool for the Reduction of Psychological Morbidity in Patients With Stage 0-IIIA Breast Cancer Receiving Radiation Therapy, COPE Study

62 enrolled

Breast Carcinoma In Situ, Breast Neoplasms

NCT07023198 2026-04-01

Clinical Breast Examination and Patient Navigation Intervention in Sub-Saharan Africa

8,000 enrolled

Breast Neoplasms

NCT02890082 2026-03-31

PRESAGE

102 enrolled

Breast Neoplasms

NCT03270072 2026-03-31

The Differential Impact of Proton Beam Irradiation Versus Conventional Radiation on Organs-at-risk in Stage II-III Breast Cancer Patients

Breast Neoplasms

NCT04067726 2026-03-31

TRIDENT

210 enrolled

Breast Neoplasms

NCT04918082 2026-03-31

Qualibreast-MQ

133 enrolled

Breast Neoplasms

NCT01525966 2026-03-30

Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer

67 enrolled 12 charts

Breast Neoplasms, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06932133 2026-03-30

Breast-POCET

600 enrolled

Breast Neoplasms

NCT07493291 2026-03-30

PALLAS-IRAQ

Phase EARLY_PHASE1 Active not recruiting

Breast Neoplasms

NCT03387553 2026-03-27

HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer

31 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT03546686 2026-03-27

Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer

51 enrolled

Breast Neoplasms

NCT04216576 2026-03-27

A Study of the Use of Text Message Reminders to Take Palbociclib

45 enrolled

Breast Neoplasms

NCT04871139 2026-03-27

An Imaging Technology, Contrast-Enhanced Mammography, in Predicting Breast Cancer